Coronary CT Angiography Versus Traditional Risk Score for Heart Disease Prevention
in Asymptomatic Chinese Adults Aged 40 to 69
Led by Zhang longjiang,MD · Updated on 2024-11-26
3400
Participants Needed
1
Research Sites
117 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether a heart disease prevention approach using coronary computed tomography angiography CCTA can improve the management of cholesterol-lowering treatments and control of cardiovascular risk factors compared to the traditional method based on cardiovascular risk scores. This study focuses on an asymptomatic Chinese population aged 40 to 69 years without known cardiovascular events. It aims to better understand the impact of CCTA screening on personalized prevention strategies and the prevalence of hidden coronary artery disease.
Participants will be randomly assigned to one of two groups one receiving prevention programs guided by CCTA results, and the other managed using traditional cardiovascular risk scores based on Chinese guidelines for lipid management. The study will include baseline assessments with questionnaires and objective evaluations on the same day as consent. Both groups will follow their respective prevention strategies, with lipid-lowering treatment and risk factor control monitored over time.
During the 12 months of follow-up, researchers will assess how many participants regularly take lipid-lowering medications and achieve LDL cholesterol targets, as well as monitor cardiovascular events, blood pressure, diabetes control, smoking cessation, exercise habits, and quality of life measures including anxiety and depression. The study will also report on the prevalence of subclinical coronary atherosclerosis detected by CCTA at baseline. The overall participation involves regular assessments to evaluate the effectiveness of the prevention strategies over one year.
CONDITIONS
Brief Title
Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population
Research Team
L
Longjiang Zhang, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Nanjing residents who have no plans to leave in the next 5 years
Aged from 40 to 69 years
Free of any known clinically cardiovascular disease
Able to comprehend and sign an informed consent form
You will not qualify if you...
Serious liver dysfunction, defined as AST or ALT greater than 3 times the normal upper limit
Chronic kidney disease stage 4 or higher, defined as eGFR less than 30 ml/min/1.73 m2
Prior CCTA or invasive coronary angiography within the last 5 years
Any contraindications for coronary computed tomography angiography (CCTA)
Previous use of statin or non-statin lipid-lowering medication such as ezetimibe, PCSK9 inhibitor, and XueZhiKang
Life expectancy less than 3 years
Other reasons the researcher deems inappropriate to attend
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Baseline
Participants undergo coronary computed tomography angiography (CCTA) or traditional cardiovascular risk stratification to guide individualized primary prevention programs for coronary heart disease.
1 baseline visit (in-person)
Long-term Monitoring
Duration - 12 months
Participants are monitored for lipid-lowering treatment adherence and cardiovascular risk factor control over 12 months.
Follow-up visits to assess treatment adherence and risk factor control
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Improving Preventive Cardiovascular Care and Health Equity in Indigenous and Remote Communities Using a Mobile Healthcare Unit
Comparison of Low-dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin for Patients with Mild to Moderate Coronary Artery Disease Without Previous Coronary Procedures
Study of Structured Clinical and Medication Management to Improve Cardiovascular Risk Factors in Adults Under Routine Care
Evaluating Intensive Versus Standard Education for Managing Dyslipidemia in Adults with Hypertension and Diabetes Aged 30 to 80
Study Comparing Pitavastatin Plus Ezetimibe Combination to High-Intensity Statin Therapy for Preventing New Diabetes in Adults with Heart Disease and Prediabetes
Trial to Determine Statin Intolerance and Rosuvastatin Tolerance in Adults with Prior Statin Side Effects
Evaluating the Willem153 AI System for Detecting Heart Failure Using Electrocardiograms in Primary Care A Randomized Clinical Trial
Study of eCardiacRehab A Hybrid Home-Based Digital Cardiac Rehabilitation Program for Patients With Coronary Artery Disease After PCI
Study of Probucol Added to Statin Therapy to Reduce Vascular Risks and Atherosclerosis in Adults with Ischemic Stroke
Comparison of Intensive Statin-Ezetimibe Therapy Without Aspirin Versus Statin With Aspirin for Preventing Heart Events in Adults with High Coronary Calcification
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Role of the screening with coronary computed tomography angiography on lipid management and risk factors control in an asymptomatic Chinese population: a community-based, parallel-group, open-label, randomized clinical trial (RESPECT2).